|
Real-time Estimate
Cboe BZX
04:22:12 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 13.24 USD | +1.57% |
|
-7.25% | +0.08% |
| 21/10 | Freenome, Inc. Launches SimpleScreenTM Lung And Personalized Cancer Detection Offering With SimpleScreen CRC | CI |
| 21/10 | Freenome Launches SimpleScreen Lung Cancer Test | MT |
Company Valuation: Freenome, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 144.2 | 1,401 | - | - |
| Change | - | 871.58% | - | - |
| Enterprise Value (EV) | 144.2 | 1,401 | 1,401 | 1,401 |
| Change | - | 871.58% | 0% | 0% |
| P/E | -1.57x | -6.62x | -5.84x | -5.74x |
| PBR | - | - | - | - |
| PEG | - | 0.1x | -0.4x | -3.5x |
| Capitalization / Revenue | - | 13.7x | 12.3x | 6.73x |
| EV / Revenue | - | 13.7x | 12.3x | 6.73x |
| EV / EBITDA | - | 1,557x | -7.92x | -8.4x |
| EV / EBIT | - | -12.1x | -6.52x | -8.16x |
| EV / FCF | - | -10.4x | -8.79x | -24x |
| FCF Yield | - | -9.58% | -11.4% | -4.17% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -8.28 | -1.97 | -2.233 | -2.27 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 102.4 | 113.8 | 208.1 |
| EBITDA 1 | - | 0.9 | -176.8 | -166.7 |
| EBIT 1 | - | -116.1 | -214.8 | -171.8 |
| Net income 1 | -219.3 | -175.1 | -245.7 | -257.7 |
| Net Debt | - | - | - | - |
| Reference price 2 | 13.03 | 13.04 | 13.04 | 13.04 |
| Nbr of stocks (in thousands) | 11,068 | 107,447 | - | - |
| Announcement Date | 30/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.62x | - | - | - | 1.4B | |
| 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 23.53x | 26.33x | 15.57x | 0.34% | 38.18B | |
| Weighted average by Cap. | 26.43x | 25.23x | 15.68x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FRNM Stock
- Valuation Freenome, Inc.
Select your edition
All financial news and data tailored to specific country editions
